fluoxetine has been researched along with gamma-cyclodextrin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruhwyler, J; Decamp, E; Dresse, A; Géczy, J; Lejeune, C; Liégeois, JF; Masset, H; Scuvée-Moreau, J; Seutin, V; Szejtli, J; Szente, L; Van Heugen, JC | 1 |
1 other study(ies) available for fluoxetine and gamma-cyclodextrin
Article | Year |
---|---|
The inclusion of fluoxetine into gamma-cyclodextrin increases its bioavailability: behavioral, electrophysiological and pharmacokinetic studies.
Topics: Adolescent; Adult; Animals; Biological Availability; Cyclodextrins; Fluoxetine; gamma-Cyclodextrins; Humans; Male; Mice; Middle Aged; Prospective Studies; Raphe Nuclei; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Swimming | 2000 |